EUVIMEDEUVIMED entdecken
Korrektur

Correction to: HNRNPC as a Novel Therapeutic Target for Ischemic Heart Disease: Evidence From Mendelian Randomization and Experimental Validation

Journal of the American Heart Association · 12.11.2026

DOI: 10.1161/jaha.125.045456 ↗

Kurz gefasst

Korrektur in der Zeitschrift Journal of the American Heart Association, online erschienen am 12.11.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to: HNRNPC as a Novel Therapeutic Target for Ischemic Heart Disease: Evidence From Mendelian Randomization and Experimental Validation. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.045456

Vancouver

Correction to: HNRNPC as a Novel Therapeutic Target for Ischemic Heart Disease: Evidence From Mendelian Randomization and Experimental Validation. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.045456

BibTeX
@article{euvimed2026,
  title = {Correction to: HNRNPC as a Novel Therapeutic Target for Ischemic Heart Disease: Evidence From Mendelian Randomization and Experimental Validation},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.125.045456}
}
Kostenlos starten →